Article
Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.
Translational research : the journal of laboratory and clinical medicine - 1 Feb 2016
Perdoni Christopher, Osborn Mark J, Tolar Jakub
Abstract excerpt
Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by mutations in the COL7A1 gene that result in absent or dysfunctional type VII collagen protein production. Clinically, RDEB manifests as early and severe chronic cutaneous blistering, damage to internal epithelium, an increased risk for squamous cell carcinoma, and an overall reduced life expectancy. Recent localized and systemic treatments...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
